Sublingual immunotherapy in children: complete and updated review supporting evidence of effect

    loading  Checking for direct PDF access through Ovid


Purpose of reviewThe interest in sublingual immunotherapy (SLIT) is still growing worldwide and especially for the pediatric age group, this modality is appealing. Lately, some negative systematic review articles have been published on SLIT in children. However, high quality articles published from 2007 onward had not been included.Recent findingsExplanations are sought for the negative outcomes in these reviews and shortcomings are discussed. New pediatric studies – not included in the previous reviews – designed taking into account the golden rules for SLIT (high daily dose, starting at least 4 months before pollen season) do show statistically significant improvement in symptom and medication scores for rhinitis and asthma in pollen allergy. New house dust mite studies still show inconsistent data.SummaryEvidence of effect is confirmed for SLIT in children with allergic rhinitis or asthma caused by pollen exposure. For house dust mite asthma, evidence is still nonconcordant. New techniques to improve SLIT efficacy are under investigation.

    loading  Loading Related Articles